“Multi-Targeted Tyrosine Kinase Inhibitor Sorafenib. Application Experience in Kidney Cancer With Lung Metastases”. Voprosy Onkologii, vol. 62, no. 1, Dec. 2016, pp. 154-6, https://doi.org/10.37469/0507-3758-2016-62-1-154-156.